Vanguard Group’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,521,404
Closed -$8.9M 4242
2019
Q1
$8.9M Buy
1,521,404
+905,682
+147% +$5.3M ﹤0.01% 2888
2018
Q4
$801K Sell
615,722
-999,720
-62% -$1.3M ﹤0.01% 3628
2018
Q3
$5.57M Buy
1,615,442
+11,006
+0.7% +$38K ﹤0.01% 3193
2018
Q2
$7.3M Buy
1,604,436
+33,533
+2% +$153K ﹤0.01% 3051
2018
Q1
$5.18M Buy
1,570,903
+218,300
+16% +$720K ﹤0.01% 3140
2017
Q4
$5.28M Buy
1,352,603
+749,883
+124% +$2.92M ﹤0.01% 3115
2017
Q3
$6.24M Buy
602,720
+77,721
+15% +$805K ﹤0.01% 3028
2017
Q2
$5.12M Buy
524,999
+144,408
+38% +$1.41M ﹤0.01% 3071
2017
Q1
$2.59M Buy
380,591
+61,729
+19% +$420K ﹤0.01% 3298
2016
Q4
$1.75M Sell
318,862
-38,746
-11% -$213K ﹤0.01% 3401
2016
Q3
$2.71M Buy
357,608
+22,675
+7% +$172K ﹤0.01% 3279
2016
Q2
$2.73M Buy
334,933
+7,941
+2% +$64.8K ﹤0.01% 3246
2016
Q1
$4.25M Buy
326,992
+4,664
+1% +$60.6K ﹤0.01% 3053
2015
Q4
$6.47M Buy
322,328
+22,409
+7% +$450K ﹤0.01% 2866
2015
Q3
$3.66M Buy
299,919
+38,766
+15% +$473K ﹤0.01% 3111
2015
Q2
$5.39M Buy
261,153
+180,150
+222% +$3.72M ﹤0.01% 2985
2015
Q1
$1.71M Buy
81,003
+20,823
+35% +$440K ﹤0.01% 3466
2014
Q4
$1.85M Buy
60,180
+47,762
+385% +$1.47M ﹤0.01% 3313
2014
Q3
$220K Buy
+12,418
New +$220K ﹤0.01% 3876